Ascorbic acid (AA) is an antioxidant molecule that is highly concentrated in the brain and can exert both anticonvulsant and proconvulsant effects in distinct models of experimental seizures. Herein, we investigated whether chronic AA administration alters cortical excitability as indexed by the cortical spreading depression (CSD). Well-nourished (W) and malnourished (M) rats were treated, by gavage, with 60 mg/kg/day of l-AA from postnatal days 7-28, and CSD propagation was analyzed at 30-40 days. Compared to the W groups, M rats presented higher (p < 0.05) CSD amplitudes and velocities of propagation. In both nutritional conditions, AA-treatment significantly increased CSD amplitudes and propagation velocities (p < 0.05), as compared to non-treated ('naïve'; Nv) and saline-treated (Sal) controls. The mean ± standard deviation CSD velocities of propagation (in mm/min) for the Sal, AA and Nv groups were respectively 3.75 ± 0.03, 4.26 ± 0.08 and 3.81 ± 0.04 for the W condition and 4.29 ± 0.08, 4.51 ± 0.04 and 4.30 ± 0.04 for the M groups. The results demonstrate a CSD-facilitation by AA regardless of nutritional status. They also suggest that, at the dose of 60 mg/kg/day chronically administered during brain development, AA may act as a prooxidant in brain, in view of the contrasting effect as compared with other antioxidants, which reduce CSD.
spontaneous electrical activity of the cerebral cortex in response to mechanical, electrical or chemical stimulation of one point on the cortical surface [23] . During CSD, cerebrovascular alterations [22] , as well as a slow negative potential change [24] have been described. The brain susceptibility to CSD can be easily estimated by measuring CSD velocity of propagation along the cortical tissue. CSD changes have been previously demonstrated in rats under conditions of environmental, pharmacological, and nutritional manipulations [1, 2, 26] . CSD has been electrophysiologically demonstrated also in the human brain [12, 14] .
Although the mechanisms underlying CSD are not yet fully clarified, several pieces of evidence suggest the participation of ionic processes [16] , as well as neurotransmitters [2] and the production of reactive oxygen species in the brain [11] . The brain is particularly vulnerable to oxidative lipid damage, because it has a high rate of oxidative metabolism [4] , and its constitution includes a high content of polyunsaturated fatty acids. This is especially critical in the immature brain [8] .
Malnutrition can cause structural, neurochemical and functional changes of organs and tissues, especially in the nervous system, both in laboratory animals [9, 29] and in humans [15, 25] . It has been well established that early malnutrition [39] , as well as enteral administration of the amino acid l-arginine [13] and glutamine [26] increase CSD propagation, but no information is available regarding systemic AA effects on CSD in vivo. In the present work, we used electrophysiological recording of CSD, in order to address the following two questions in the brain of weaned young rats, subjected to malnutrition during lactation followed by nutritional recovery: (i) How does daily enteral administration of AA during the brain development affect CSD propagation, and (ii) if so, how would this effect be influenced by the previous brain nutritional condition. We were able to demonstrate a facilitation effect of AA that is not appreciably modified by malnutrition.
Wistar rats (n = 65) from the colony of Departamento de Nutriç ão of Universidade Federal de Pernambuco (Brazil) born from several dams were pooled at birth and then randomly distributed to form litters with six pups per nurse and assigned to two nutritional groups according to the mother's dietary conditions: well-nourished group (W, n = 33), suckled by dams fed a commercial laboratory chow diet (Purina do Brasil LTDA), containing 23% protein, and malnourished group (M, n = 32), suckled by dams fed a Regional Basic Diet (RBD), containing 7.87% protein, that mimics the low-income human populations diet of Northeastern Brazil [43] . Both nutritional groups were subdivided in three other groups according to the daily treatment during lactation days 7-28: (i) group Sal, (ii) group AA, receiving respectively, per gavage, saline and 60 mg/kg/day AA (Sigma-Aldrich), as previously described [4] and (iii) group "naïve" (Nv) receiving no gavage. The handling procedures involving the animals were in accordance with the Institution's guidelines, which comply with the "Principles of Laboratory Animal Care" (National Institutes of Health, Bethesda, USA). Animals were reared in polypropylene cages (51 cm × 35.5 cm × 18.5 cm) in a room maintained at 22 ± 1 • C with a 12 h light/12 h dark cycle (lights on at 7:00 a.m.) with free access to water and food.
The surgical procedure was performed as previously described [1] with little modification. Briefly, under anesthesia (1 g/kg urethane plus 40 mg/kg chloralose, i.p.) three trephine holes (2-3 mm in diameter) were made on the right side of the skull, parallel to the midline. The first hole (on the frontal bone) was used to apply the stimulus to elicit CSD. The other two holes (on the parietal bone) were used to record the propagating CSD wave. Rectal temperature was continuously monitored and maintained at 37 ± 1 • C by a heating blanket.
CSD was elicited at 20 min intervals by applying, for 1 min, a cotton ball (1-2 mm diameter), soaked in 2% KCl solution (approximately 0.27 M) to the anterior hole drilled at the frontal region. The electrocorticogram (ECoG) depression and the DC-potential change typical of CSD were recorded simultaneously at the two parietal points on the cortical surface by using a pair of Ag-AgCl agar-Ringer electrodes. A common reference electrode, of the same type, was placed on the nasal bones. The velocity of CSD propagation was calculated based on the time required for a CSD wave to cross the distance between the 2 recording electrodes. In the measurement of CSD velocities, the initial point of each DC negative rising phase was used as the reference point. After finishing the recording session, the animal, while anesthetized, was submitted to euthanasia by bulbar injury. This was carried out by introducing a sharp needle into the cisterna magna, provoking immediate cardio-respiratory arrest.
Body weights, and CSD propagation rates and amplitudes of the negative DC-shift of CSD were compared by two-way ANOVA including as factors: nutritional status (W and M) and gavage treatment (Sal, AA and Nv) followed by a post hoc (Tukey-Kramer) test when indicated. Differences were considered significant when p ≤ 0.05. All values are presented in the text as means ± standard deviations.
At the day of the CSD recording, animals of the M-groups presented lower (p < 0.001) body weights as compared with those of the W-groups. The mean ± standard deviation body weights (in g) 
Table 1
Amplitudes of the CSD negative slow potential shifts in the 6 groups of rats (3 wellnourished and 3 malnourished groups) treated per gavage with saline, ascorbic acid, or kept non-treated (naïve group). Data are expressed as mean ± standard deviation. Asterisks indicate that the CSD-amplitudes in the groups treated with ascorbic acid are significantly higher (p < 0.05) than their corresponding naïve and saline controls. The symbol # shows that the malnourished groups presented higher CSD amplitudes (p < 0.05) as compared with the corresponding well-nourished groups (two-way ANOVA followed by Tukey test).
Groups
Amplitudes In all groups, topical application of 2% KCl for 1 min at the frontal cortex reproducibly elicited a single CSD wave, which propagated and was recorded at two points in the parieto-occipital region of the stimulated hemisphere. Examples of CSD episodes in 2 wellnourished and 2 malnourished rats (one Sal and one AA animal from each nutritional condition) can be seen in the ECoG-and DCpotential change recordings presented in Fig. 1 .
The amplitudes of the negative slow potential shift of CSD and the CSD propagation velocities are presented in Table 1 and Fig. 2 , respectively. In W animals the mean ± standard deviation CSD velocities were (in mm/min) 3.75 ± 0.11, 4.26 ± 0.25 and 3.81 ± 0.13 for the Sal, AA and Nv groups, respectively. In the M rats the CSD velocities were 4.29 ± 0.26, 4.51 ± 0.12 and 4.30 ± 0.14 for the Sal, AA and NV groups, respectively. ANOVA revealed a main effect of the nutrition condition and the Tukey test indicated that both CSD slow potential shift amplitudes, and propagation velocities were higher in the malnourished rats, as compared to the corresponding well-nourished controls (p < 0.05). Independent of the nutritional status, a main effect of the gavage condition was also detected. The Tukey test revealed that the treatment with AA significantly increased the CSD slow potential shift amplitudes and the CSD propagation velocities (p < 0.05), as compared with the two control groups (Nv and Sal), which presented comparable CSD values (Table 1 and Fig. 2 ).
The present findings constitute the first description of the effects of systemic application of AA on CSD in the developing rat brain. Our data suggest that brain developmental changes are produced by early chronic AA administration and this is causally associated with the facilitation of CSD propagation. Such effect is unlikely to be caused by the stress associated to the gavage procedure, since no CSD alteration was observed in the control groups that have been equally submitted to the gavage. Interestingly, malnutrition did not seem to modulate it.
In the present study, malnutrition was surely indicated by the significantly lower body weights in the M groups, when compared to their respective W controls, confirming previous report [38] . Malnutrition is known to impair the organism's development, with repercussions on vital organs, including the brain. It may lead to a deficiency in processes like synapse formation, dendritic development and myelination [29, 36] . These processes may be involved in the present facilitating CSD effects associated to malnutrition, which is in accordance with previous reports demonstrating that malnutrition facilitates CSD in the rat brain [3, 26, 38] . Alteration in the action of synaptic neurotransmitters, increase in the brain cell packing density, and reduction in the brain myelination are factors that have been postulated to be involved in the CSD facilitation in the malnourished brain [10, 38] . Concerning the role of brain myelination in CSD, an inverse correlation has been recently demonstrated in animal models in which the myelination pattern has been altered by means of genetic (hypermyelinated transgenic animals), immunological (cortical hypomyelination produced by immunization against myelin) and dietary approaches [27] . These authors have shown that the more myelinated the cortex was, the lower was the CSD velocity of propagation, and vice versa, indicating a dichotomous modulation of the myelin participation in the CSD effects. In overfed and malnourished rats, a similar dietdependent dichotomous modulation has also been found, with CSD deceleration in overfed rats and acceleration in malnourished rats, as compared to the well-nourished controls [39] .
Early malnourished animals can present diminished [18, 45] , equal [2, 17] , or enhanced [44] changes in brain CSD reaction in response to the administration of distinct substances, such as, respectively, glucose and diazepam (diminished CSD responses in the malnourished brain), citalopram and fluoxetine (equal CSD responses) and pilocarpine (enhanced CSD responses). We presently found that early malnutrition did not change the AA effect on CSD. Taken together, these findings collectively indicate that the malnourished brain may present distinct CSD responsiveness to different pharmacological agents. If, in the human species, this could be extrapolated to other neural actions of distinct drugs, the possible clinical implication would be that one such drug could have different effectiveness, as a function of the early nutritional status of the patient. This possibility should be diligently investigated in the medical clinic.
Concerning the CSD-antioxidants relationship, previous studies demonstrated that the production of reactive oxygen species can elicit CSD in the isolated chicken retina [33] and in the rat cortex [11] . Also, the antioxidant astaxanthin impairs the chronic ethanol facilitating effect on CSD propagation [1] . In contrast to that findings, in the present study animals treated with AA show an increase in CSD velocities and DC-shift amplitudes. AA is a strong water soluble reducing agent known to act normally as an antioxidant, both in vivo and in vitro [6] . It is effective in scavenging free radicals including reactive oxygen species, protecting the lipids from oxidation [37] . Antioxidant molecules are also important in protecting the brain against free radicals, particularly in neurodegenerative diseases [42] . However, in vivo [4] as well as in vitro [21, 41] evidence suggest that, depending on the conditions under which AA is acting, it can also have prooxidant action, and thus can cause neurotoxicity. Furthermore, AA can exert both anticonvulsant and proconvulsant effects in the brain [5, 34] . According to Halliwell [19] various non-radical compounds including AA can produce reactive radical species in the presence of transition metal ions in the brain. Based on the above reports, and also considering that in the present study the daily AA treatment per gavage was long-lasting (22 days), it is tempting to speculate that this body of evidence would constitute a possible explanation for our present findings on CSD facilitation by AA. To the best of our knowledge, no data are available in the literature regarding a relationship of prooxidants and enhancement of CSD amplitude/propagation. It is possible that, at the dose of 60 mg/kg/day, administered chronically during a period of intense neural development, as in the present study, AA may act as prooxidant in the brain, as suggested by the larger CSD DC-shifts and the faster CSD propagation, observed in the AA animals. The measurement of blood-and brain reactive oxygen species levels, as well as treating developing rats with lower AA doses, or treating developed animals, shall confirm this hypothesis in future experiments. Also, the role of AA in redox mechanisms at the glutamate synapse [40] , and the AA-nitric oxide interaction in excitability-related neuropathological phenomena [35, 46] shall deserve further investigation.
In conclusion, our data have demonstrated that chronic AA treatment of developing animals enhances CSD, and this effect is not modulated by early malnutrition. These novel findings are consistent with the hypothesis that, at the dose of 60 mg/kg/day, AA can have a prooxidant effect, as previous evidence indicates [4] .
